Fortis Bannerghatta named India's top kidney transplant centre for robotic innovation

Fortis Hospital, Bannerghatta Road in Bengaluru has been named one of India's top kidney transplant centres. The recognition came at the FICCI Advantage Healthcare India 2026 event. The hospital is known for its advanced medical infrastructure and expertise in multiple specialties.

The award highlights its leadership in renal care, particularly through the innovative TREAT Program, which uses robotic technology for complex transplants. The TREAT Program (Total Robot Enabled and Assisted Transplant) was launched in India by Fortis Bannerghatta. It allows surgeons to perform simultaneous robot-assisted procedures on both donor and recipient. This method is especially valuable for high-risk patients, including those with obesity, multiple health conditions, or previous transplant histories.

The hospital's reputation extends beyond India, attracting patients from Africa, the Middle East, and South East Asia. Its success in kidney transplants is credited to a combination of cutting-edge surgical techniques and a focus on patient-centred care. Dr. Mohan Keshavamurthy, Principal Director of Renal Sciences, emphasised that high-quality treatment and innovation drive the program's achievements.

Beyond renal care, Fortis Bannerghatta is recognised for excellence in oncology, neurosciences, urology, and cardiac sciences. Mr. Gautham CB, the facility's director, stated that the award reflects the hospital's dedication to clinical excellence, technological advancement, and accessible world-class healthcare. The recognition at FICCI Advantage Healthcare India 2026 confirms Fortis Bannerghatta's position as a leading transplant centre. Its use of robotic surgery and specialised programs like TREAT has expanded treatment options for complex cases. The hospital continues to serve as a key healthcare destination for both domestic and international patients.